Adherence to Otezla | Peearz Health

NOT_YET_RECRUITING

I'm interested ...!!

Adherence to Otezla

Most people with psoriasis have very limited disease, yet that disease may still have a large impact on their lives. While limited psoriasis may be amenable to topical treatment, patients are exceptionally poorly adherent to topical treatment, especially over the long run.

Conditions:

Psoriasis

Study Start (Actual) 2024-07

Primary Completion (Estimated) 2024-12

Study Completion (Estimated) 2025-02

Enrollment (Estimated) 84

Study Type INTERVENTIONAL

Phase EARLY_PHASE1

Locations:

📍 Winston-Salem, North Carolina, United States

Eligibility Criteria

Description

Inclusion Criteria:

* Adult 18 years or older
* Diagnosis of mild psoriasis with Otezla recommendation
* Non-pregnant
* English speaking

Exclusion Criteria:

* Under 18 years of age
* Not diagnosis of mild psoriasis
* Pregnant
* Non-English speaking

Ages Eligible for Study: 18 Years to 85 Years (ADULT, OLDER_ADULT)

Sexes Eligible for Study: ALL

Accepts Healthy Volunteers: No

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted2022-10-13
First Submitted that Met QC Criteria2022-10-26
First Posted2022-11-01

Study Record Updates

Last Update Submitted that Met QC Criteria2024-05-22
Last Update Posted2024-05-23
Last Verified2024-05